Escitalopram Appeal
We acted for Alphapharm Pty Ltd during the Full Federal Court appeal from the decision of a single judge of the Federal Court of Australia in respect of pharmaceutical patent revocation and infringement proceedings. The patent in issue purports to cover the anti-depressant medicine escitalopram (marketed as Lexapro) and is owned by a Dutch company, H Lundbeck A/S, and licensed to its Australian subsidiary, Lundbeck Australia Pty Ltd.
Esco Inc and Bradken Resources v CQMS and Pac Mining - patent litigation
We act for Esco and Bradken who have patents relating to ground engaging tools for mining applications. These proceedings allege that CQMS and Pac Mining infringe those patents. This proceeding is part of an overall strategy of Esco to enforce its patents against competitors in an industry where replacement parts for wear members is extensive.
Uniline v Sbriggs - patent litigation
We are acting for Sbriggs Pty Ltd which has been sued by Uniline for unjustified threats of patent and design infringement. Our client has countersued for patent and design infringement. The patent and design relates to spring clutches for the smooth operation of domestic and commercial blinds. This case is likely to bring forward the question of whether there can be design infringement by the assembly of components in the final product notwithstanding that those components in the unassembled form would not infringe.
Innovation Patent dispute over low GI white bread
We acted for Quality Bakers Australia Pty Limited, in Federal Court proceedings bought by George Weston Foods Limited. At issue was infringement and validity of an innovation patent owned by George Weston, in relation to Low GI (glycaemic index) white bread. The case is significant as at this time, no case concerning an innovation patent had been heard by the Federal Court.
Novartis Vaccines and Diagnostics Inc. -v- SmithKline Beecham Biologicals SA - Federal Court - patent litigation
This was an appeal by SKB Inc from Novartis' successful opposition to SKB's patent application for a multivalent ('multishot') vaccine. SKB's patent application has been litigated in many jurisdictions by Novartis. We were retained by FB Rice (leading Australian life science patent attorneys) to act for Novartis and contest SKB's appeal to the Federal Court.